Next Generation News and Research

RSS

Ambry Genetics and SoftGenetics sign agreement for next-generation sequencing projects at Ambry

Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics' NextGENe software for next-generation sequencing projects performed at Ambry.

4 Dec 2009

Pfizer announces a $9M cancer research collaboration in British Columbia

Pfizer is entering into a three-year, $9-million research collaboration with the BC Cancer Agency and the Vancouver Prostate Centre, a University of British Columbia (UBC) and Vancouver General Hospital (VGH) Centre of Excellence, to tackle new treatment avenues for breast, ovarian and prostate cancer. This is the single-largest investment by Pfizer into British Columbia's public research sector, and it recognizes the strength and world-class cancer expertise that resides in this province.

4 Dec 2009

GTSI named value-added reseller of the Intel Health Guide RPM solution

GTSI Corp. an enterprise technology solutions and services provider was recently named a value-added reseller to deliver the Intel® Health Guide, a comprehensive, next-generation remote patient monitoring (RPM) solution that combines an in-home patient device, the Intel Health Guide PHS6000, with the Intel® Care Management Suite, an online interface that allows clinicians to monitor patients and remotely manage care.

3 Dec 2009

CLC bio, imaGenes announce collaboration in high-throughput sequencing analyses

Today, the leading provider of High-Throughput Sequencing analysis solutions, CLC bio, announced that they're collaborating with premier German sequencing service provider, imaGenes, to better support the fast growing German market of high-throughput sequencing analyses. imaGenes, will provide all customers receiving Next Generation Sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.

3 Dec 2009

PharmAthene to present its biological/ chemical weapons countermeasure program data at the HHS PHEMCE workshop

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company will participate in and present data at the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) workshop and BARDA Industry Day taking place in Washington, DC Dec. 2-4, 2009.

2 Dec 2009

NuGEN Technologies launches its next generation Ovation RNA-Seq System

NuGEN Technologies, Inc., a pace-setter in genomic sample preparation, enters the next generation sequencing (NGS) market today with its Ovation RNA-Seq System, a revolutionary method of sample preparation that broadens research horizons with a more comprehensive representation of the transcriptome created from samples of a few hundred picograms.

2 Dec 2009

Cancer Genomic Microarray Facility selects febit's Geniom RT Analyzer to advance its biomedical research

The Cancer Genomic Microarray Facility at the Kimmel Cancer Center of the Thomas Jefferson University, Philadelphia, selected febit's Geniom® RT Analyzer to advance its biomedical research by proceeding targeted Next-Generation Sequencing (NGS), genome-wide single nucleotide polymorphism (SNP) and microRNA (miRNA) analysis.

2 Dec 2009

Canadians with hemophilia A can use new treatment option, XYNTHA

Canadians with hemophilia A - a rare, inherited blood-clotting disorder - now have a new treatment option with the introduction of XYNTHA(TM), a recombinant factor VIII product for both the control and prevention of bleeding episodes and surgical prophylaxis.

2 Dec 2009

ASH to host annual High School Student Symposium at New Orleans Marriott

The American Society of Hematology (ASH) will host its annual High School Student Symposium at the New Orleans Marriott on Thursday, December 3, at 8:00 a.m. CST.

1 Dec 2009

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

Akonni Biosystems, a molecular diagnostics (MDx) company focused on providing rapid and highly scalable solutions for infectious disease testing, today announced receipt of a $3.2M Phase II SBIR grant from the National Institutes of Health (NIH).

1 Dec 2009

Scientists and engineers explore synergies in moving oil and pumping blood

Scientists and engineers from two of the nation's largest industries - medicine and energy - will come together Dec. 7 with leading academicians to explore the synergies in moving oil and pumping blood.

1 Dec 2009

Verisk Health announces the release of DxCG Risk Solutions 3.0

Verisk Health, Inc., a global leader in healthcare data analytics, today announced the release of DxCG Risk Solutions 3.0, a suite of risk adjustment and predictive modeling products that enable organizations to analyze, predict, manage, and minimize healthcare risk and costs associated with commercial, Medicare, and Medicaid populations.

1 Dec 2009

CPR/AED education program for teens

Be the Beat, the American Heart Association's new online cardiac arrest awareness campaign, teaches 12- to 15-year-olds fun ways to learn the basics of cardiopulmonary resuscitation (CPR) and how to use an automated external defibrillator (AED).

30 Nov 2009

Xencor licenses its XmAb and Xtend technology platforms to Centocor Research & Development

Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation and biosuperior antibodies, announced today that it has licensed its XmAb® and Xtend™ technology platforms to Centocor Research & Development, Inc. for the optimization of Centocor’s antibody drug candidates.

30 Nov 2009

ALS research collaboration receives philanthropic funding

Three prominent philanthropic organizations – The Angel Fund, The ALS Therapy Alliance and Project ALS -- dedicated to finding a treatment for amyotrophic lateral sclerosis (ALS) have financed a new collaboration between one of the world’s leading ALS researchers and RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi).

30 Nov 2009

Medipattern, Sentinelle Medical sign technology access and distribution agreement

The Medipattern Corporation (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity and Sentinelle Medical Inc., a leading manufacturer of magnetic resonance imaging (MRI) coils and advanced visualization software, have announced that they are entering a technology access and distribution agreement.

30 Nov 2009

VIDA Diagnostics and Veran Medical to develop and market endobronchial lung navigation and biopsy system

VIDA Diagnostics, a leading developer of quantitative imaging software for the advanced analysis of pulmonary diseases, and Veran Medical Technologies, a leader in minimally invasive delivery of interventional oncology therapies, announced the companies have signed a definitive agreement covering joint development and distribution of an endobronchial lung navigation and biopsy system.

30 Nov 2009

Virtual Imaging to introduce latest imaging solutions and additions to its RadPRO product line

Virtual Imaging, Inc., a Canon U.S.A, Inc. company, will introduce the latest imaging solutions and additions to its RadPRO® product line at the 2009 Radiological Society of North America (RSNA 2009) Annual Meeting in Chicago November 29 – December 3 (Hall B, booth # 8339).

29 Nov 2009

Sectra launches new breast imaging PACS workstation built on Sectra RapidConnect technology

At RSNA 2009, Sectra launches a new breast imaging PACS workstation built on Sectra RapidConnect™ technology. With this next-generation mammography workstation, Sectra focuses on customer productivity and wide area radiology.

28 Nov 2009

OSEO awards fund for Galapagos NV's antibody therapeutics program

Galapagos NV announces that its antibody therapeutics program with MorphoSys and SARM program have been awarded funding by the French governmental organization OSEO.

26 Nov 2009

Next Generation News and Research

Ambry Genetics and SoftGenetics sign agreement for next-generation sequencing projects at Ambry

Pfizer announces a $9M cancer research collaboration in British Columbia

GTSI named value-added reseller of the Intel Health Guide RPM solution

CLC bio, imaGenes announce collaboration in high-throughput sequencing analyses

PharmAthene to present its biological/ chemical weapons countermeasure program data at the HHS PHEMCE workshop

NuGEN Technologies launches its next generation Ovation RNA-Seq System

Cancer Genomic Microarray Facility selects febit's Geniom RT Analyzer to advance its biomedical research

Canadians with hemophilia A can use new treatment option, XYNTHA

ASH to host annual High School Student Symposium at New Orleans Marriott

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

Scientists and engineers explore synergies in moving oil and pumping blood

Verisk Health announces the release of DxCG Risk Solutions 3.0

CPR/AED education program for teens

Xencor licenses its XmAb and Xtend technology platforms to Centocor Research & Development

ALS research collaboration receives philanthropic funding

Medipattern, Sentinelle Medical sign technology access and distribution agreement

VIDA Diagnostics and Veran Medical to develop and market endobronchial lung navigation and biopsy system

Virtual Imaging to introduce latest imaging solutions and additions to its RadPRO product line

Sectra launches new breast imaging PACS workstation built on Sectra RapidConnect technology

OSEO awards fund for Galapagos NV's antibody therapeutics program

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News